Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For LBG.L
Valuation Weak
28%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Weak
33%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q3 Q4 Δ in %
Current Ratio 0.00 2.85 2.85
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 66.88 -0.73 -2.19
Naive Interpretation member
2 Per Share
Metric Q3 Q4 Δ in %
Book Value 0.02 0.32 0.32
Cash 0.02 0.08 0.08
Capex -164.80 < 0.005 < 0.005
Free Cash Flow 40.81 < 0.005 < 0.005
Revenue 100.04 0.19 0.10
Naive Interpretation member
3 Profitability
Metric Q3 Q4 Δ in %
Gross Margin -33.73 0.30 0.46
Operating Margin 6.84 0.30 0.28
ROA 193.76 0.04 0.01
ROE 193.76 0.05 0.02
ROIC 146.50 0.08 0.03
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of LBG.L is permitted for members.
5 Growth
The "Growth Entry" for the Focus of LBG.L is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of LBG.L is permitted for members.